A yearlong royalties strife between Genmab and its partner Janssen was finally over in April, when three arbitrators ruled in favor of the latter firm.
Wiping the slate clean with the release of its first quarterly report for 2022, Genmab has announced that it will not seek a review of the award, effectively bringing the entire ordeal to an end. According to CEO Jan van de Winkel, Genmab is now looking to the future.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Demant rejects criticisms of lobbying efforts against OTC channel: "That’s how America works"
To ensure users receive a high-quality device, CEO Søren Nielsen says Demant has lobbied the FDA through a US-based industry association as it attempts to established the rules for the upcoming over-the-counter hearing aids sales channel.
Sonova downgrades, blames high costs and weak results from key markets
The hearing aid giant now expects revenue growth of 15-19% measured in local currencies, compared to a previous 17-21%.
Demant CEO highlights strong performance from Diagnostics, acknowledges Communications letdown
The Danish hearing aid manufacturer’s diagnostics business area is a beacon of light among gloomy H1 financial figures, mostly coming from headset firm Epos, says CEO Søren Nielsen.
Analyst to hone in on Vyepti rollout and patient uptake in imminent Lundbeck report
The preventive migraine treatment, Vyepti, will likely be a key element of the Danish pharmaceutical firm’s upcoming second quarterly report on Wednesday.
US downswing reflects shift in underlying demand, says Demant CEO
Demand for hearing aids on the US market will return in the future, according to Demant CEO Søren Nielsen, who thinks people are postponing the decision to acquire a device due to the challenging economic environment.
Sales Director, Nordic Hospital Solutions, at Mediq Denmark 
GMP Compliance Consultant for Eltronic in Ballerup 
Clinical Project/Trial Manager, Synklino 
Key Account Manager 
Senior Evidence Generation Manager 
Clinical Biometrics Oversight Lead 
Antibody Engineering Scientist 
Clinical Trial Manager - Black Swans Exist 
Global Quality Director (Business Unit Quality Lead) 
Senior Clinical Trial Manager - Black Swans Exist 
Director Regulatory Affairs 
Experienced Biostatistician